Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents: An Alternative Strategy for Inhibition of Restenosis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Circulation

• Publication date

  2004-07-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000133324.38115.0APMID 15210598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Copyright

  2005cited by this paper
• Mobilized Endothelial Progenitor Cells by Granulocyte-Macrophage Colony-Stimulating Factor Accelerate Reendothelialization and Reduce Vascular Inflammation After Intravascular Radiation

  2003cited by this paper
• Estrogen-Mediated, Endothelial Nitric Oxide Synthase–Dependent Mobilization of Bone Marrow–Derived Endothelial Progenitor Cells Contributes to Reendothelialization After Arterial Injury

  2003cited by this paper
• A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

  2002cited by this paper
• A RANDOMIZED COMPARISON OF A SIROLIMUS-ELUTING STENT WITH A STANDARD STENT FOR CORONARY REVASCULARIZATION

  2002cited by this paper
• Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells

  2002cited by this paper
• Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts.

  2002cited by this paper
• First Clinical Experience With a Paclitaxel Derivate–Eluting Polymer Stent System Implantation for In-Stent Restenosis: Immediate and Long-Term Clinical and Angiographic Outcome

  2002cited by this paper
• Histopathologic Alterations after Endovascular Radiation and Antiproliferative Stents: Similarities and Differences

  2002cited by this paper
• Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

  2002cited by this paper
• Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study

  2001cited by this paper
• In Vivo Blockade of Tumor Necrosis Factor-&agr; Accelerates Functional Endothelial Recovery After Balloon Angioplasty

  2001cited by this paper
• Living the dream of no restenosis.

  2001cited by this paper
• Late Arterial Responses (6 and 12 Months) After 32P &bgr;-Emitting Stent Placement: Sustained Intimal Suppression With Incomplete Healing

  2001cited by this paper
• Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated Stent

  2001cited by this paper
• Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting.

  2001cited by this paper
• Late acute thrombosis after paclitaxel eluting stent implantation

  2001cited by this paper
• Reversal of experimental diabetic neuropathy by VEGF gene transfer.

  2001cited by this paper
• Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries

  2000cited by this paper
• Italian BiodivYsio open registry (BiodivYsio PC-coated stent): study of clinical outcomes of the implant of a PC-coated coronary stent.

  2000cited by this paper
• Effect of statin therapy on restenosis after coronary stent implantation.

  2000cited by this paper
• Gene delivery from a DNA controlled-release stent in porcine coronary arteries

  2000cited by this paper
• Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial.

  2000cited by this paper
• Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis.

  2000cited by this paper
• Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.

  1998cited by this paper
• VEGF Gene Transfer Reduces Intimal Thickening via Increased Production of Nitric Oxide in Carotid Arteries

  1997cited by this paper
• Histopathology of in-stent restenosis in patients with peripheral artery disease.

  1997cited by this paper
• Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening.

  1997cited by this paper
• Estradiol accelerates functional endothelial recovery after arterial injury.

  1997cited by this paper
• Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimal formation.

  1997cited by this paper
• The microtubule-affecting drug paclitaxel has antiangiogenic activity.

  1996cited by this paper
• Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study.

  1996cited by this paper
• Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer.

  1996cited by this paper
• Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.

  1995cited by this paper
• The endothelium as a regulator of vascular smooth muscle proliferation

  1993cited by this paper
• Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry.

  1993cited by this paper
• Prevention of smooth muscle cell outgrowth from human atherosclerotic plaque by a recombinant cytotoxin specific for the epidermal growth factor receptor.

  1993cited by this paper
• Repopulation of injured arteries with genetically modified endothelial cells.

  1992cited by this paper
• Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model.

  1992cited by this paper
• Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation.

  1990cited by this paper
• Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty.

  1990cited by this paper
• Seeding of intravascular stents with genetically engineered endothelial cells.

  1989cited by this paper
• Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: the problem of restenosis.

  1989cited by this paper
• Recombinant gene expression in vivo within endothelial cells of the arterial wall.

  1989cited by this paper
• Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation.

  1989cited by this paper
• Implantation of vascular grafts lined with genetically modified endothelial cells.

  1989cited by this paper
• Morphology of the endothelium over atherosclerotic plaques in human coronary arteries.

  1988cited by this paper
• Endothelialization of Intravascular Stents

  1988cited by this paper
• Pathologic characteristics of recurrent carotid artery stenosis.

  1987cited by this paper
• Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses.

  1985cited by this paper
• Postoperative carotid restenosis due to neointimal fibromuscular hyperplasia. Clinical, angiographic, and pathological findings.

  1983cited by this paper
• Augmentation of regional coronary blood flow by intra-aortic balloon counterpulsation in patients with unstable angina.

  1983cited by this paper
• Integrity of vein grafts as a function of initial intimal and medial preservation.

  1983cited by this paper
• Enhanced patency of small-diameter, externally supported Dacron iliofemoral grafts seeded with endothelial cells.

  1982cited by this paper
• Protection of Endothelium in Vessel Segments Excised for Grafting

  1981cited by this paper
• A morphologic and permeability study of luminal smooth muscle cells after arterial injury in the rat.

  1978cited by this paper
• A morphologic and permeability study of luminal smooth muscle cells after arterial injury in the rat.

  1978cited by this paper
• Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening.

  1975cited by this paper
• Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening.

  1975cited by this paper
• Experimental aortic intimal thickening. I. Morphology and source of intimal cells.

  1974cited by this paper
• Arterial repair and atherosclerosis after mechanical injury. 5. Tissue response after induction of a large superficial transverse injury.

  1973cited by this paper

• The Past, Present, and Future of Cardiac Gene Therapy.

  2026cites this paper
• Nitric Oxide in Biomaterial-Based Therapies for Coronary Heart Disease: Mechanistic Insights, Current Advances, and Translational Prospects

  2025cites this paper
• The Role of VEGF in Intervention-Mediated Injuries: Neointimal Hyperplasia and In-Stent Restenosis

  2025cites this paper
• Endovascular Drug Delivery

  2024cites this paper
• Advancements in Omics and Breakthrough Gene Therapies: A Glimpse into the Future of Peripheral Artery Disease.

  2024cites this paper
• Endothelialization of coronary stents after intra-luminal adenoviral VEGF-A gene transfer in a preclinical porcine restenosis model - Studies with optical coherence tomography, angioscopy, multiphoton and scanning electron microscopy.

  2024cites this paper
• Vascular Endothelial Growth Factor Genetic Variant Is Associated with in-Stent Restenosis after Percutaneous Coronary Intervention

  2022cites this paper
• Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies

  2022cites this paper
• Endothelial‐Smooth Muscle Cell Interactions in a Shear‐Exposed Intimal Hyperplasia on‐a‐Dish Model to Evaluate Therapeutic Strategies

  2022cites this paper
• What Went Wrong with VEGF-A in Peripheral Arterial Disease? A Systematic Review and Biological Insights on Future Therapeutics

  2022cites this paper
• Covalent functionalization of decellularized tissues accelerates endothelialization

  2021cites this paper
• Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.

  2021cites this paper
• miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis

  2021cites this paper
• Recent Advances in Manufacturing Innovative Stents

  2020cites this paper
• Release mechanisms and applications of drug delivery systems for extended-release

  2020cites this paper
• Recent advances in cardiovascular stent for treatment of in-stent restenosis: Mechanisms and strategies

  2020cites this paper
• Molecular basis of cardiovascular disease

  2020cites this paper
• Mechanical and physio-biological properties of peptide-coated stent for re-endothelialization

  2020cites this paper
• Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

  2020cites this paper
• Competitive Flow Effects of Internal Mammary Artery Bypass with Different Coronary Stenosis Lengths

  2019cites this paper
• Photothermal Spongy Film for Enhanced Surface-Mediated Transfection to Primary Cells.

  2019cites this paper
• Prevention of in-stent restenosis with endothelial progenitor cell (EPC) capture stent placement combined with regional EPC transplantation: An atherosclerotic rabbit model

  2019cites this paper
• Reduction-Responsive Nucleic Acid Delivery Systems To Prevent In-Stent Restenosis in Rabbits.

  2019cites this paper
• Recent alternative approaches of vascular drug-eluting stents

  2018cites this paper
• Coatings for biomaterials to improve hemocompatibility

  2018cites this paper
• Arterial Thrombosis in Patients with Cancer

  2018cites this paper
• Gene therapy in cardiovascular diseases: A review of recent updates

  2018cites this paper
• 7 Gene Therapy in Cardiovascular Disease

  2018cites this paper
• Chapter 3.3 – Gene Therapy

  2018cites this paper
• The CIRSE Research Infrastructure: our 5-year experience

  2018cites this paper
• Stent‐mediated gene and drug delivery for cardiovascular disease and cancer: A brief insight

  2017cites this paper
• Drug- and Gene-eluting Stents for Preventing Coronary Restenosis

  2017cites this paper
• The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis.

  2017cites this paper
• In vitro basic fibroblast growth factor (bFGF) delivery using an antithrombogenic 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer coated with a micropatterned diamond-like carbon (DLC) film.

  2017cites this paper
• USE OF PODOCAN PROTEIN IN TREATING CARDOVASCULAR DISEASES Inventors:

  2017cites this paper
• Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings.

  2017cites this paper
• Nanomaterial coatings applied on stent surfaces.

  2016cites this paper
• The metamorphosis of vascular stents: passive structures to smart devices

  2016cites this paper
• Magnetic nanosphere-guided site-specific delivery of vascular endothelial growth factor gene attenuates restenosis in rabbit balloon-injured artery.

  2016cites this paper
• Nanobiomedicine Emerging Strategies and Applications of Layer-by-layer Self-Assembly Review Article

  2016cites this paper
• Re-Endothelialization Study on Endovascular Stents Seeded by Endothelial Cells through Up- or Downregulation of VEGF.

  2016cites this paper
• Rescuing Impaired Re-endothelialization of Drug-Eluting Stents Using the Hepatocyte Growth Factor.

  2016cites this paper
• Gene Delivery from Stents for Prevention of In-Stent Restenosis

  2016cites this paper
• Advances in stent-mediated gene delivery

  2016influential citation
• Bioengineering stents with proactive biocompatibility

  2015cites this paper
• Medical Stents : State of the Art and Future Directions Coronary Stent Materials and Coatings : A Technology and Performance Update

  2015cites this paper
• The (PrS/HGF-pDNA) multilayer films for gene-eluting stent coating: Gene-protecting, anticoagulation, antibacterial properties, and in vivo antirestenosis evaluation.

  2015cites this paper
• Quantification of Adventitial Vasa Vasorum Vascularization in Double-injury Restenotic Arteries

  2015cites this paper
• Use of Biomaterials and Biomolecules for the Prevention of Restenosis

  2015influential citation
• Inhibition of intimal hyperplasia via local delivery of vascular endothelial growth factor cDNA nanoparticles in a rabbit model of restenosis induced by abdominal aorta balloon injury.

  2015cites this paper
• Association between mobilization of circulating endothelial progenitor cells and time or degree of injury from angioplasty in patients with exertional angina: A prospective study.

  2015cites this paper
• Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis

  2014influential citation
• Endothelial progenitor cell (EPC)-seeded intravascular stents

  2014cites this paper
• Nanotechnology Applications in Local Arterial Drug Delivery

  2014cites this paper
• Chemical activation and changes in surface morphology of poly(ε-caprolactone) modulate VEGF responsiveness of human endothelial cells

  2014cites this paper
• Alternative approaches to the prevention of coronary In-stent restenosis

  2014cites this paper
• - Regulatory Requirements for Medical Devices, Including Combinations with Biological Products or Drugs as an Integral Part

  2014cites this paper
• Gene therapy for in-stent restenosis: Targets and delivery system

  2014influential citation
• Polyelectrolyte Multilayers as Functional Coatings for Controlled Biomolecular Interactions

  2014cites this paper
• An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents.

  2014cites this paper
• Chapter 39 – Blood Vessels

  2014cites this paper
• Emerging Strategies and Applications of Layer-by-Layer Self-Assembly

  2014cites this paper
• Endothelial remodelling and intracellular calcium machinery.

  2014cites this paper
• Role of biomaterials in prevention of in-stent restenosis.

  2014cites this paper
• Arterial Wall Remodeling and Restenosis Following Vascular Reconstruction

  2013cites this paper
• Modulation of NO and ROS production by AdiNOS transduced vascular cells through supplementation with L-Arg and BH4: implications for gene therapy of restenosis.

  2013cites this paper
• E-Selectin Mediated Adhesion and Migration of Endothelial Colony Forming Cells Is Enhanced by SDF-1α/CXCR4

  2013cites this paper
• Nanotechnology-based gene-eluting stents.

  2013cites this paper
• Surface-mediated functional gene delivery: an effective strategy for enhancing competitiveness of endothelial cells over smooth muscle cells.

  2013cites this paper
• Gene delivery strategies targeting stable atheromatous plaque.

  2013cites this paper
• Restenosis after PCI. prevention and therapy

  2013cites this paper
• The effects of stenting on shear stress: relevance to endothelial injury and repair.

  2013cites this paper
• Reduction of intimal hyperplasia in injured rat arteries promoted by catheter balloons coated with polyelectrolyte multilayers that contain plasmid DNA encoding PKCδ.

  2013cites this paper
• Clinical and Translational Challenges in Gene Therapy of Cardiovascular Diseases

  2013cites this paper
• Inception to actualization: next generation coronary stent coatings incorporating nanotechnology.

  2013cites this paper
• Statins and stem cell modulation.

  2013cites this paper
• Recent advances in drug eluting stents.

  2013cites this paper
• Adenoviral vector tethering to metal surfaces via hydrolyzable cross-linkers for the modulation of vector release and transduction.

  2013cites this paper
• Polyelectrolyte multilayers promote stent-mediated delivery of DNA to vascular tissue.

  2013cites this paper
• The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent.

  2013cites this paper
• Endovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents

  2013cites this paper
• Restenosis and Therapy

  2012cites this paper
• Accelerating endothelialization of coronary stents by capturing circulating endothelial progenitor cells

  2012cites this paper
• Site Specific Controlled Release for Cardiovascular Disease: Translational Directions

  2012cites this paper
• Endothelial Progenitor Cells in the Treatment of Vascular Disease

  2012cites this paper
• Nonviral Gene Delivery for Applications in Regenerative Medicine

  2012cites this paper
• Prevention of coronary in-stent restenosis and vein graft failure: does vascular gene therapy have a role?

  2012cites this paper
• Coatings for cardiovascular devices: coronary stents

  2012cites this paper
• Molecular Imaging of Vascular Endothelial Growth Factor Receptors in Graft Arteriosclerosis

  2012cites this paper
• Nanotechnology in interventional cardiology.

  2012cites this paper
• The ligands of CXCR4 in vascularization

  2012cites this paper
• Nonviral delivery of genetic medicine for therapeutic angiogenesis.

  2012cites this paper
• Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury

  2012cites this paper
• Restenosis after PCI. Part 2: prevention and therapy

  2012cites this paper
• Biomedical Applications of Biomimetic Polymers: The Phosphorylcholine‐Containing Polymers

  2012cites this paper
• Magnetic field-assisted gene delivery: achievements and therapeutic potential.

  2011cites this paper
• Biosynthetic Pathways and the Role of the Mas Receptor in the Effects of Angiotensin-(1–7) in Smooth Muscles

  2011cites this paper
• Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model

  2011cites this paper
• Stem cells and growth factor delivery systems for cardiovascular disease.

  2011cites this paper
• Targeting oxidative stress after percutaneous coronary intervention

  2011cites this paper